Democratizing hedge fund level analysis tools for everyone
| Name | Phapros Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| PT. Kimia Farma Tbk | 56.77 | 56.77 |
| Public < 5% | 32.77 | 32.77 |
| Masrizal A. Syarief | 10.46 | 10.46 |
| Source | 2022 | 2021 |
|---|---|---|
| PEHA | F2 | Generic Drugs Bearing |
| PEHA | F2 | Ethical |
| PEHA | F2 | Over The Counter |
| PEHA | F2 | Toll-in |
| PEHA | F2 | Others |
| Region | 2022 | 2021 |
|---|---|---|
| PEHA | F2 | Indonesia |
| PEHA | F2 | Others |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 0.31 | # 4 / 15 |
| EV_EBITDA | 11.06 | # 7 / 15 |
| PER | 59.15 | --- / 15 |
| PBV | 0.71 | # 2 / 15 |
| DER | 2.69 | # 10 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | 0.5205000000000001 | # 11 / 15 |
| ROA % | 0.33 | # 11 / 15 |
| ROE % | 1.2 | # 12 / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2023 | 26.74 | 4.2 |
| 2022 | 15.82 | 2.4 |
| 2021 | 46.18 | 4.2 |
| 2020 | 170.06 | 10.0 |
| 2019 | 220.52 | 20.6 |
| Timeframe | Performance |
|---|---|
| 1W % | 0.0 |
| 1Mo % | 5.0 |
| 3Mo % | -0.6 |
| 1Yr % | -13.0 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 15.76 | 62.26 T | 63.77 T | 34,159 B | 5,862 B | 3,950 B |
| SOHO | 44.61 | 25.89 T | 28.01 T | 10,338 B | 711 B | 581 B |
| SIDO | 14.24 | 17.10 T | 16.78 T | 3,657 B | 1,604 B | 1,201 B |
| TSPC | 8.97 | 12.63 T | 11.54 T | 13,197 B | 1,807 B | 1,404 B |
| PYFA | -13.79 | 5.90 T | 11.63 T | 2,771 B | -27 B | -426 B |
| KAEF | -8.56 | 3.48 T | 14.83 T | 8,673 B | 365 B | -409 B |